Discontinued Operations (Tables)

3 Months Ended

Mar. 31, 2024

Discontinued Operations and Disposal Groups [Abstract]

Schedule of Disposal Groups Including Discontinued Operations

A summary of the results from discontinued operations included in the Condensed Consolidated Statements of Operations and Comprehensive Loss follows:

	Three Months Ended March 31,
	2024		2023
	(in thousands)
Revenues:
Non-Insurance revenue	$	6,824	$	205,783
Total revenues	6,824		205,783
Operating Expenses:
Net medical claims incurred	$	2,235	$	197,701
General and administrative expenses	292		990
Restructuring costs	297		—
Total operating expenses	$	2,824	$	198,691
Gain from operations	4,000		7,092
Net income	$	4,000	$	7,092

A summary of the carrying amounts of major assets and liabilities, which were classified as held for settlement in the Condensed Consolidated Balance Sheets, follows:

	March 31, 2024		December 31, 2023
	(in thousands)
Assets(1)
Cash and cash equivalents	$	—	$	6,456
Surety bond and deposits	—		55,089
Non-Insurance receivable	10,926		10,926
Total assets	$	10,926	$	72,471
Liabilities(1)
Unpaid claims	$	858	$	2,856
Accounts payable and accrued expenses	297		—
Accrued salaries and benefits	—		110
Non-Insurance performance year obligation, current	9,657		15,568
Non-Insurance payable	39,810		41,565
Total liabilities	$	50,622	$	60,099

(1) The assets and liabilities of the disposal group classified are classified as current on the March 31, 2024 Condensed Consolidated Balance Sheet as the settlement with CMS is expected to occur within one year.

A summary of cash flows from discontinued operations included in the Condensed Consolidated Statements of Cash Flows follows:

	Three Months Ended March 31,
	2024		2023
	(in thousands)
Net cash (used in) provided by operating activities	$	(8,019)	$	17,109

Schedule of Performance Guarantees

The tables below include the financial statement impacts of the performance guarantee:

	March 31, 2024		December 31, 2023
	(in thousands)
Non-Insurance performance year obligation (1)	$	9,657	$	15,568
(1) This obligation represents the consideration due to providers, net of the shared savings or loss for the period and amortization of the liability.

	Three Months Ended March 31,
	2024		2023
	(in thousands)
Amortization of the Non-Insurance performance year receivable	$	—	$	(184,207)
Amortization of the Non-Insurance performance year obligation	—		184,207
Non-Insurance revenue	$	6,824	$	205,783

Schedule of Restructuring Charges

The Restructuring costs are presented in the Company's Condensed Consolidated Statements of Operations and Comprehensive Loss, which were as follows:

Three Months Ended March 31,	2024		2023
	(in thousands)
Employee termination benefits	$	—	$	1,226
Vendor related costs	349		581
Other	4		—
Total restructuring costs	$	353	$	1,807

The Restructuring costs are presented in the Company's Condensed Consolidated Statements of Operations and Comprehensive Loss, which were as follows:

ACO REACH

As of March 31, 2024 and December 31, 2023, the liability for employee termination benefits was recorded in Accrued salaries and benefits and the liability for vendor related costs and other expenses were recorded in Accounts payable and accrued expenses in the discontinued operations balance sheets. The liability recorded reflects the Company's best estimate, which may be revised in subsequent periods as the restructuring progresses.

	Employee Termination Benefits		Vendor related costs		Total
	(in thousands)
Liability as of December 31, 2023	$	110	$	—	$	110
Charges	—		297		297
Cash payments	(110)		—		(110)
Liability as of March 31, 2024	$	—	$	297	$	297
Total cumulative costs incurred as of March 31, 2024	$	110	$	297	$	407